|
Anticoagulant mechanisms
Citations 1-10 of 73 total displayed.
|
Most recent content
(3 Jun 2008):
|
- Correspondence
Letter by Augoustides Regarding Article "Aprotinin Does Not Increase the Risk of Renal Failure in Cardiac Surgery Patients"
- John G.T. Augoustides
Circulation 2008; 117: e474, doi:10.1161/CIRCULATIONAHA.107.744045
[Full text]
- Correspondence
Letter by Bouchard et al Regarding Article "Aprotinin Does Not Increase the Risk of Renal Failure in Cardiac Surgery Patients"
- Josée Bouchard, Roy Mathew, and Ravindra L. Mehta
Circulation 2008; 117: e475, doi:10.1161/CIRCULATIONAHA.107.747030
[Full text]
|
Past content
(since Jan 1999):
|
- Correspondence
Letter by de Boer and van Veldhuisen Regarding Article, "Risk of Thromboembolism in Heart Failure: An Analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)"
- Rudolf A. de Boer and Dirk J. van Veldhuisen
Circulation 2008; 117: e7, doi:10.1161/CIRCULATIONAHA.107.725440
[Full text]
- Editorials
Bleeding Is Bad.... Isn’t It?
- Peter B. Berger and Steven V. Manoukian
Circulation 2007; 116: 2776-2778, doi:10.1161/CIRCULATIONAHA.107.743534
[Full text]
- Contemporary Reviews in Cardiovascular Medicine
Beyond Unfractionated Heparin and Warfarin: Current and Future Advances
- Jack Hirsh, Martin O’Donnell, and John W. Eikelboom
Circulation 2007; 116: 552-560, doi:10.1161/CIRCULATIONAHA.106.685974
[Full text]
- Contemporary Reviews in Cardiovascular Medicine
Conundrums in the Combined Use of Anticoagulants and Antiplatelet Drugs
- David J. Schneider and Burton E. Sobel
Circulation 2007; 116: 305-315, doi:10.1161/CIRCULATIONAHA.106.655910
[Full text]
- Clinician Update
Prevention of Pulmonary Embolism in General Surgery Patients
- Urszula Zurawska, Sudha Parasuraman, and Samuel Z. Goldhaber
Circulation 2007; 115: e302-307e, doi:10.1161/CIRCULATIONAHA.106.674663
[Full text]
- Vascular Medicine
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation 114: 2490 -2497; published online before print as doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
[Full text]
- Articles
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology. A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation published November 13, 2006, doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
- Cardiology Patient Pages
Heparin-Induced Thrombocytopenia
- Steven A. Baroletti and Samuel Z. Goldhaber
Circulation 2006; 114: e355-356e, doi:10.1161/CIRCULATIONAHA.106.632653
[Full text]
|
|
